-
(单词翻译:双击或拖选)
The FDA considers the nation's next round of vaccines2 to battle COVID-19
The Food and Drug Administration is meeting on Tuesday to make an extremely difficult but important decision: Should vaccines be updated to target the omicron variant4?
A MARTINEZ, HOST:
The Food and Drug Administration meets today to plan the nation's next round of vaccines to battle COVID-19. NPR's Rob Stein reports.
ROB STEIN, BYLINE5: The most powerful weapons the country has to coexist with the virus are the vaccines. They're what turns a potentially deadly disease into something more like a cold or the flu for many people. And the new technology the Moderna and Pfizer-BioNTech vaccines use gives scientists the power to update the shots quickly by simply reprogramming the genetic6 code in the vaccines to match whatever strain poses the biggest threat. And many independent experts think that's exactly what the FDA should do. Here's Deepta Bhattacharya. He's an immunobiologist at the University of Arizona.
DEEPTA BHATTACHARYA: Very clearly, I think what they should be doing is recommending that probably all vaccines include a component7 of omicron in there.
STEIN: To update the vaccines for another round of boosters in the fall to protect against what could be yet another dangerous surge this coming winter. But big questions remain. Would it make sense to go with a vaccine1 that only targets omicron or with a so-called bivalent vaccine that targets both the original strain of the virus and omicron? Moderna and Pfizer and BioNTech say they've developed new vaccines targeting omicron that should provide powerful, potentially longer-lasting protection. But others aren't so sure about switching up the vaccines. John Moore is an immunologist at Weill Cornell Medicine.
JOHN MOORE: Superficially, it sounds good, that this is what should be done because omicron variants8 are what is now dominating the U.S. and global pandemic. But the details cast significant doubt on whether switching to an omicron-based vaccine is justified9.
STEIN: For starters, the new omicron vaccines appear to only stimulate10 the immune system to generate slightly higher levels of antibodies that can neutralize11 omicron. So it may make more sense to stick with the original vaccines since they still seem to be protecting most people from getting really sick or dying. Another big concern is the updated vaccines target the original strain of omicron. But new omicron sub-variants that are even better at dodging12 the immune system have already replaced it. Dr. Peter Hotez is a vaccine expert at the Baylor College of Medicine.
PETER HOTEZ: Omicron is already in the rearview mirror. And it's not clear that that's going to be useful anymore.
STEIN: So the FDA has raised the possibility of going even further, updating the COVID-19 vaccines more like the flu vaccines to anticipate where the virus may be heading. The country could, for example, go with new vaccines that target two new, even more contagious13 omicron sub-variants that have just now started taking over in the U.S. known as BA.4 and five. But that raises even more questions. Are we there yet with vaccines that use technology that's still so new to target a virus that's still so unpredictable? Who knows whether an entirely14 different strain could have taken over by next winter, rendering15 even that kind of vaccine less effective. Dr. Ofer Levy16 at Harvard is a member of an FDA advisory17 committee that will grapple with all of this today.
OFER LEVY: It's a delicate time. It's going to be a complicated deliberation. We don't have all the information we'd like. But we don't get to just sit around and speculate forever and wait for more and more information because the fall, winter are arriving. We have new variants that are spreading rapidly.
STEIN: And while the vaccines can be updated faster than older vaccine technology, it still can't happen overnight. The companies need time to test and then manufacture the millions of doses that would be needed to allow the country to live safely with the virus.
Rob Stein, NPR News.
(SOUNDBITE OF FLOBAMA'S "PIKASSO")
1 vaccine | |
n.牛痘苗,疫苗;adj.牛痘的,疫苗的 | |
参考例句: |
|
|
2 vaccines | |
疫苗,痘苗( vaccine的名词复数 ) | |
参考例句: |
|
|
3 transcript | |
n.抄本,誊本,副本,肄业证书 | |
参考例句: |
|
|
4 variant | |
adj.不同的,变异的;n.变体,异体 | |
参考例句: |
|
|
5 byline | |
n.署名;v.署名 | |
参考例句: |
|
|
6 genetic | |
adj.遗传的,遗传学的 | |
参考例句: |
|
|
7 component | |
n.组成部分,成分,元件;adj.组成的,合成的 | |
参考例句: |
|
|
8 variants | |
n.变体( variant的名词复数 );变种;变型;(词等的)变体 | |
参考例句: |
|
|
9 justified | |
a.正当的,有理的 | |
参考例句: |
|
|
10 stimulate | |
vt.刺激,使兴奋;激励,使…振奋 | |
参考例句: |
|
|
11 neutralize | |
v.使失效、抵消,使中和 | |
参考例句: |
|
|
12 dodging | |
n.避开,闪过,音调改变v.闪躲( dodge的现在分词 );回避 | |
参考例句: |
|
|
13 contagious | |
adj.传染性的,有感染力的 | |
参考例句: |
|
|
14 entirely | |
ad.全部地,完整地;完全地,彻底地 | |
参考例句: |
|
|
15 rendering | |
n.表现,描写 | |
参考例句: |
|
|
16 levy | |
n.征收税或其他款项,征收额 | |
参考例句: |
|
|
17 advisory | |
adj.劝告的,忠告的,顾问的,提供咨询 | |
参考例句: |
|
|